Product Introduction
Zyrova F 5/145 mg Tablet combines Rosuvastatin, a statin, and Fenofibrate, a lipid-lowering agent. This dual-action formula helps in managing mixed dyslipidemia, particularly in patients with co-existing elevated LDL and triglycerides. It is especially helpful in high-risk individuals for cardiovascular events.
Uses
-
Mixed dyslipidemia (high LDL + high triglycerides)
-
Hypercholesterolemia
-
Hypertriglyceridemia
-
Cardiovascular risk reduction in diabetics and obese patients
Benefits
-
Lowers bad cholesterol (LDL) and triglycerides
-
Increases good cholesterol (HDL)
-
Reduces risk of atherosclerosis and heart disease
-
Ideal for patients not controlled by a single lipid-lowering agent
Composition (per tablet)
-
Rosuvastatin – 5 mg
-
Fenofibrate (as Fenofibric Acid) – 145 mg
Side Effects
-
Muscle pain or weakness (myopathy)
-
Abdominal pain
-
Nausea
-
Elevated liver enzymes
-
Headache
-
Flatulence
Report any unexplained muscle pain or dark-colored urine to your doctor immediately.
Safety Advice
-
Not for use during pregnancy or breastfeeding
-
Regular monitoring of liver function and lipid levels is recommended
-
Avoid alcohol while on this medication
-
May not be suitable for patients with severe kidney or liver disease
-
Take with meals to improve absorption and reduce stomach upset
Usage Instructions:
-
Take once daily, preferably with food
-
Do not skip doses; follow doctor’s instructions precisely
-
Maintain a low-fat diet and exercise routine for best results
-
Do not stop abruptly without consulting your doctor
Note: Lifestyle changes like healthy diet, weight control, and regular exercise are essential alongside this medication for optimal cholesterol management.
